Rachel Lenington Athira Pharma, Inc. (ATHA) insider trading activity

ATHA Quotes by TradingView

Rachel Lenington is COO and CDO of Athira Pharma, Inc.. Currently has a direct ownership of 20,870 shares of ATHA, which is worth approximately $8,974. The most recent transaction as insider was on Sep 05, 2024, when has been sold 2,525 shares (Common Stock) at a price of $0.57 per share, resulting in proceeds of $1,439. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.9K
55.8% 3M change
259.39% 12M change
Total Value Held $8,974

Rachel Lenington Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 05 2024
SELL
Open market or private sale
$1,439 $0.57 p/Share
2,525 Reduced 10.79%
20,870 Common Stock
Sep 03 2024
BUY
Grant, award, or other acquisition
-
10,000 Added 29.94%
23,395 Common Stock
Jan 05 2024
SELL
Open market or private sale
$7,018 $2.91 p/Share
2,412 Reduced 15.26%
13,395 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
10,000 Added 38.75%
15,807 Common Stock
Jun 23 2022
SELL
Open market or private sale
$11,279 $2.69 p/Share
4,193 Reduced 41.93%
5,807 Common Stock
Jun 22 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 50.0%
10,000 Common Stock
RL

Rachel Lenington

COO and CDO
Bothell, WA

Track Institutional and Insider Activities on ATHA

Follow Athira Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATHA shares.

Notify only if

Insider Trading

Get notified when an Athira Pharma, Inc. insider buys or sells ATHA shares.

Notify only if

News

Receive news related to Athira Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATHA